Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Management of Hyperglycemia in COVID-19 and Post-COVID-19 Syndrome - Proposed Guidelines for India.

Tytuł:
Management of Hyperglycemia in COVID-19 and Post-COVID-19 Syndrome - Proposed Guidelines for India.
Autorzy:
Nanditha A; Director, Consultant Diabetologist, India Diabetes Research Foundation and Dr. A. Ramachandran's Diabetes Hospitals, Chennai, Tamil Nadu.
Raghavan A; Director, Consultant Diabetologist, India Diabetes Research Foundation and Dr. A. Ramachandran's Diabetes Hospitals, Chennai, Tamil Nadu.
Misra A; Chairman, Fortis-C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology, Chairman, National Diabetes, Obesity and Cholesterol Foundation (N-DOC), President, Diabetes Foundation (India) (DFI), New Delhi.
Saboo B; Chief Diabetologist Chairman, Diabetes Care Hormone Clinic, Ahmedabad, Gujarat.
Singh AK; Senior Consultant Endocrinologist, G.D Hospital Diabetes Institute, Kolkata, West Bengal.
Joshi SR; Senior Consultant Endocrinologist, Lilavati Hospital and Medical Research Centre, Mumbai, Maharashtra.
Agarwal S; Director - Aegle Clinic for Diabetes Care, Head of Dept. Medicine Diabetes, Ruby Hall Clinic. Senior Consultant Diabetes Medicine, Jehangir Hospital, Pune, Maharashtra.
Tandon N; Professor Head, Department of Endocrinology Metabolism, All India Institute of Medical Sciences, New Delhi.
Tiwaskar M; Consultant Physician Diabetologist, Shilpa Medical Research Centre, Mumbai, Maharashtra.
Aravind SR; Director, Diacon Hospital, Bangalore, Karnataka; 10President, India Diabetes Research Foundation, Chairman, Dr. A. Ramachandran's Diabetes Hospitals, Chennai, Tamil Nadu.
Ramachandran A; President, India Diabetes Research Foundation, Chairman, Dr. A. Ramachandran's Diabetes Hospitals, Chennai, Tamil Nadu.
Źródło:
The Journal of the Association of Physicians of India [J Assoc Physicians India] 2021 Sep; Vol. 69 (9), pp. 11-12.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Publication: Bombay : Association of Physicians of India
Original Publication: Bombay [1953?]-
MeSH Terms:
COVID-19*/complications
Hyperglycemia*/etiology
Hyperglycemia*/therapy
Humans ; India/epidemiology ; SARS-CoV-2 ; Post-Acute COVID-19 Syndrome
Entry Date(s):
Date Created: 20210929 Date Completed: 20211001 Latest Revision: 20221207
Update Code:
20240105
PMID:
34585892
Czasopismo naukowe
SARS-CoV-2 virus spread rapidly all over the globe in 2020 and the second wave has taken our nation, India by storm. The pandemic has posed unique challenges in people with metabolic disorders, including diabetes, hypertension, obesity, pulmonary, cardiovascular, kidney and non-alcoholic fatty liver disease. Uncontrolled diabetes, in conjunction with endocrine, inflammatory and metabolic effects of the infection itself has made management of hyperglycemia in COVID-19 infection particularly challenging. Furthermore, the post-COVID-19 syndrome has also emerged as a sequela in COVID-19 survivors, increasing the risk of death, complications and adding further burden on the health care system. With more than a year of experience, we have gained substantial insight; and now provide practical recommendations on the management of hyperglycemia in COVID-19 as well as post COVID-19 syndrome.
(© Journal of the Association of Physicians of India 2011.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies